These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 35857310)
1. SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination. Moore T; Hossain R; Doores KJ; Shankar-Hari M; Fear DJ Viral Immunol; 2022 Jul; 35(6):425-436. PubMed ID: 35857310 [TBL] [Abstract][Full Text] [Related]
2. A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials. Bisceglia H; Barrier J; Ruiz J; Pagnon A J Immunol Methods; 2023 Apr; 515():113457. PubMed ID: 36914088 [TBL] [Abstract][Full Text] [Related]
3. Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination. Astakhova EA; Byazrova MG; Yusubalieva GM; Kulemzin SV; Kruglova NA; Prilipov AG; Baklaushev VP; Gorchakov AA; Taranin AV; Filatov AV Cells; 2022 Jun; 11(13):. PubMed ID: 35805076 [TBL] [Abstract][Full Text] [Related]
4. Early human B cell signatures of the primary antibody response to mRNA vaccination. Kardava L; Rachmaninoff N; Lau WW; Buckner CM; Trihemasava K; Blazkova J; Lopes de Assis F; Wang W; Zhang X; Wang Y; Chiang CI; Narpala S; McCormack GE; Liu C; Seamon CA; Sneller MC; O'Connell S; Li Y; McDermott AB; Chun TW; Fauci AS; Tsang JS; Moir S Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2204607119. PubMed ID: 35759653 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects. Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009 [TBL] [Abstract][Full Text] [Related]
6. mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection. Casado JL; Vizcarra P; Martín-Hondarza A; Gómez-Maldonado S; Muedra-Sánchez M; Del Pino J; Mirabella IG; Martín-Colmenarejo S; Haemmerle J; Fernández-Escribano M; Vallejo A Front Immunol; 2023; 14():1127379. PubMed ID: 37457694 [TBL] [Abstract][Full Text] [Related]
7. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses. Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA; Cell Rep; 2022 Feb; 38(6):110345. PubMed ID: 35090598 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients. Gurevich M; Zilkha-Falb R; Sonis P; Magalashvili D; Menascu S; Flechter S; Dolev M; Mandel M; Achiron A Int J Infect Dis; 2022 Feb; 115():208-214. PubMed ID: 34896265 [TBL] [Abstract][Full Text] [Related]
9. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
10. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG. Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590 [TBL] [Abstract][Full Text] [Related]
11. Frequencies of SARS-CoV-2 Spike Protein-Specific Memory B Cells in Human PBMCs, Quantified by ELISPOT Assay. Swanson IM; Haralambieva IH; Rasche MM; Ovsyannikova IG; Kennedy RB Methods Mol Biol; 2024; 2768():153-166. PubMed ID: 38502393 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis. Farroni C; Picchianti-Diamanti A; Aiello A; Nicastri E; Laganà B; Agrati C; Castilletti C; Meschi S; Colavita F; Cuzzi G; Casetti R; Grassi G; Petrone L; Vanini V; Salmi A; Repele F; Altera AMG; Maffongelli G; Corpolongo A; Salemi S; Di Rosa R; Nalli G; Sesti G; Vaia F; Puro V; Goletti D Front Immunol; 2022; 13():846753. PubMed ID: 35309297 [TBL] [Abstract][Full Text] [Related]
13. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection. Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andréll J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarström L; Baldanti F; Marcotte H; Pan-Hammarström Q Med; 2021 Mar; 2(3):281-295.e4. PubMed ID: 33589885 [TBL] [Abstract][Full Text] [Related]
14. Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Casado JL; Vizcarra P; Martín-Hondarza A; Blasco M; Grandal-Platero M; Haemmerle J; Fernández-Escribano M; Vallejo A Viruses; 2023 Feb; 15(3):. PubMed ID: 36992336 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Seroconversion in Response to Infection and Vaccination: a Time Series Local Study in Brazil. Huergo LF; Paula NM; Gonçalves ACA; Kluge CHS; Marins PHSA; Camargo HSC; Sant'Ana TP; Farias LRP; Aldrighi JD; Lima ÊS; Jacotenski GT; Vargas LR; Costa G; Weissheimer KV; Nazário MG; Teixeira KN; Conzentino MS Microbiol Spectr; 2022 Aug; 10(4):e0102622. PubMed ID: 35770982 [TBL] [Abstract][Full Text] [Related]
16. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine. Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR Front Immunol; 2022; 13():827306. PubMed ID: 35173736 [TBL] [Abstract][Full Text] [Related]